Literature DB >> 26265284

Long non-coding RNA HOTTIP promotes tumor growth and inhibits cell apoptosis in lung cancer.

H-P Deng1, L Chen1, T Fan1, B Zhang1, Y Xu1, Q Geng2.   

Abstract

Lung cancer is one of the leading causes of cancer-related deaths worldwide. Early diagnosis is the best defense against this threat and is therefore of vital importance. In this study, we investigated the role of long non-coding RNA HOTTIP in the tumor growth of lung cancer. Initially, we found that expression of HOTTIP was significantly elevated in 20 cases of lung cancer. HOTTIP was also differentially expressed in a consecutive of lung cancer cell lines. Furthermore, specific shRNA against HOTTIP was employed to deplete expression of HOTTIP in A549 cells and NCI-H446 cells. After successfully depletion of HOTTIP, cell proliferation and colony formation were significantly inhibited in vitro. Tumor growth in vivo was also suppressed after depletion of HOTTIP in a mouse model of lung cancer. Moreover, depletion of HOTTIP caused cell cycle arrest in G0/G1 phase and induced significant cell apoptosis. Cell cycle regulators Cdc25C, Cyclin B1 and Cyclin D1 were decreased upon depletion of HOTTIP. Pro-apoptotic factor Bad was up-regulated, whereas anti-apoptotic factors Bcl-2 and Bcl-xL were down-regulated after HOTTIP ablation. These data suggest that lncRNA HOTTIP contributes to tumor growth in vivo and in vitro and inhibits cell apoptosis in lung cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26265284

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  15 in total

1.  Transcriptional and posttranscriptional regulation of HOXA13 by lncRNA HOTTIP facilitates tumorigenesis and metastasis in esophageal squamous carcinoma cells.

Authors:  C Lin; Y Wang; Y Wang; S Zhang; L Yu; C Guo; H Xu
Journal:  Oncogene       Date:  2017-05-22       Impact factor: 9.867

2.  Long non-coding RNA HOXA transcript at the distal tip as a biomarker for gastric cancer.

Authors:  Yuchong Yang; Bin Ma; Ying Yan; Yongxi Song; Peng Gao; Jingxu Sun; Jiajun Wang; Zhenning Wang
Journal:  Oncol Lett       Date:  2017-05-17       Impact factor: 2.967

3.  Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response.

Authors:  Wei-Jing Gong; Ji-Ye Yin; Xiang-Ping Li; Chao Fang; Di Xiao; Wei Zhang; Hong-Hao Zhou; Xi Li; Zhao-Qian Liu
Journal:  Tumour Biol       Date:  2016-01-05

4.  The long noncoding RNA LINC01207 promotes proliferation of lung adenocarcinoma.

Authors:  Gongchao Wang; Hongbo Chen; Jun Liu
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

5.  Overexpression of long noncoding RNA HOTTIP promotes tumor invasion and predicts poor prognosis in gastric cancer.

Authors:  Heng Ye; Kun Liu; Keqing Qian
Journal:  Onco Targets Ther       Date:  2016-04-07       Impact factor: 4.147

6.  miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation.

Authors:  Tongbao Feng; Fang Shao; Qiyong Wu; Xiaohang Zhang; Dongqin Xu; Keqing Qian; Yewen Xie; Shizhong Wang; Ning Xu; Yong Wang; Chunjian Qi
Journal:  Oncotarget       Date:  2016-03-29

Review 7.  Roles of long noncoding RNAs in colorectal cancer metastasis.

Authors:  He Li; Si-Qing Ma; Jin Huang; Xiao-Ping Chen; Hong-Hao Zhou
Journal:  Oncotarget       Date:  2017-06-13

Review 8.  The prognostic value of long noncoding RNA HOTTIP on clinical outcomes in breast cancer.

Authors:  Yinlong Yang; Jinxian Qian; Youqun Xiang; Yizuo Chen; Jinmiao Qu
Journal:  Oncotarget       Date:  2017-01-24

Review 9.  Intersecting transcriptomic profiling technologies and long non-coding RNA function in lung adenocarcinoma: discovery, mechanisms, and therapeutic applications.

Authors:  Jonathan Castillo; Theresa R Stueve; Crystal N Marconett
Journal:  Oncotarget       Date:  2017-06-09

10.  A novel long non-coding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer.

Authors:  Yiran Liang; Xiaojin Song; Yaming Li; Yuting Sang; Ning Zhang; Hanwen Zhang; Ying Liu; Yi Duan; Bing Chen; Renbo Guo; Wenjing Zhao; Lijuan Wang; Qifeng Yang
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.